The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 14, 2024
Filed:
Nov. 03, 2022
Applicant:
Actuate Therapeutics Inc., Fort Worth, TX (US);
Inventors:
Francis Giles, Fort Worth, TX (US);
Andrew Mazar, Fort Worth, TX (US);
Assignee:
ACTUATE THERAPEUTICS INC., Fort Worth, TX (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/407 (2006.01); A61K 31/433 (2006.01); A61K 31/52 (2006.01); A61K 31/5377 (2006.01); A61K 31/5517 (2006.01); A61K 31/635 (2006.01); A61P 35/02 (2006.01);
U.S. Cl.
CPC ...
A61K 31/407 (2013.01); A61K 31/433 (2013.01); A61K 31/52 (2013.01); A61K 31/5377 (2013.01); A61K 31/5517 (2013.01); A61K 31/635 (2013.01); A61P 35/02 (2018.01);
Abstract
Methods of treating malignant lymphoproliferative disorders in a patient, comprising administering an effective amount of a GSK-3β inhibitor, for example 9-ING-41, are provided. Also provided are methods for treating malignant lymphoproliferative disorders comprising administering a GSK-3β inhibitor, for example 9-ING-41, in combination with a second or multiple therapeutic agents.
Giles, Francis. (2024). Methods of treating malignant lymphoproliferative disorders (U.S. Patent No. 11980607). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11980607
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile